BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gabolde M, Hubert D, Guilloud-Bataille M, Lenaerts C, Feingold J, Besmond C. The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosis. J Med Genet 2001;38:310-1. [PMID: 11333866 DOI: 10.1136/jmg.38.5.310] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Mendizabal M, Reddy KR, Cassuto J, Olthoff KM, Faust TW, Makar GA, Rand EB, Shaked A, Abt PL. Liver transplantation in patients with cystic fibrosis: Analysis of united network for organ sharing data: Liver Transplantation in Patients with Cystic Fibrosis. Liver Transpl 2011;17:243-50. [DOI: 10.1002/lt.22240] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
2 Guardia A, Lozano F. Mannose-binding lectin deficiencies in infectious and inflammatory disorders: . Reviews in Medical Microbiology 2003;14:41-52. [DOI: 10.1097/00013542-200304000-00001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
3 Arroyo M, Crawford JM. Hepatitic inherited metabolic disorders. Seminars in Diagnostic Pathology 2006;23:182-9. [DOI: 10.1053/j.semdp.2006.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
4 Gruden-Movsesijan A. [Mannose-binding protein--a factor in congenital immune reactions]. Vojnosanit Pregl 2003;60:67-75. [PMID: 12688114 DOI: 10.2298/vsp0301067g] [Reference Citation Analysis]
5 Miller MR, Sokol RJ, Narkewicz MR, Sontag MK. Pulmonary function in individuals who underwent liver transplantation: From the US cystic fibrosis foundation registry: Pulmonary Function in Individuals with Cystic Fibrosis. Liver Transpl 2012;18:585-93. [DOI: 10.1002/lt.23389] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
6 Henrion-Caude A, Flamant C, Roussey M, Housset C, Flahault A, Fryer AA, Chadelat K, Strange RC, Clement A. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Hepatology 2002;36:913-7. [PMID: 12297838 DOI: 10.1053/jhep.2002.35534] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
7 Tomaiuolo R, Degiorgio D, Coviello D, Baccarelli A, Elce A, Raia V, Motta V, Seia M, Castaldo G, Colombo C. An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: A multicentre study. Digestive and Liver Disease 2009;41:817-22. [DOI: 10.1016/j.dld.2009.03.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
8 Prentice B, Mckay K, Selvadurai H, Robinson PD, Abel F, Fitzgerald DA. Question 6: Is there a role for Mannose-Binding Lectin measurement in Cystic Fibrosis management? Paediatric Respiratory Reviews 2016;19:46-8. [DOI: 10.1016/j.prrv.2015.09.008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
9 Weiler CA, Drumm ML. Genetic influences on cystic fibrosis lung disease severity. Front Pharmacol. 2013;4:40. [PMID: 23630497 DOI: 10.3389/fphar.2013.00040] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
10 Chalmers JD, Fleming GB, Hill AT, Kilpatrick DC. Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis. Glycobiology 2011;21:271-82. [PMID: 21045008 DOI: 10.1093/glycob/cwq161] [Cited by in Crossref: 50] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
11 Lewindon PJ, Pereira TN, Hoskins AC, Bridle KR, Williamson RM, Shepherd RW, Ramm GA. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease. Am J Pathol. 2002;160:1705-1715. [PMID: 12000722 DOI: 10.1016/s0002-9440(10)61117-0] [Cited by in Crossref: 91] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
12 Colombo C. Liver disease in cystic fibrosis. Curr Opin Pulm Med. 2007;13:529-536. [PMID: 17901760 DOI: 10.1097/mcp.0b013e3282f10a16] [Cited by in Crossref: 115] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
13 Carlsson M, Sjöholm AG, Eriksson L, Thiel S, Jensenius JC, Segelmark M, Truedsson L. Deficiency of the mannan-binding lectin pathway of complement and poor outcome in cystic fibrosis: bacterial colonization may be decisive for a relationship. Clin Exp Immunol 2005;139:306-13. [PMID: 15654829 DOI: 10.1111/j.1365-2249.2004.02690.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 3.2] [Reference Citation Analysis]
14 Collardeau-Frachon S, Bouvier R, Le Gall C, Rivet C, Cabet F, Bellon G, Lachaux A, Scoazec JY. Unexpected diagnosis of cystic fibrosis at liver biopsy: a report of four pediatric cases. Virchows Arch 2007;451:57-64. [PMID: 17554556 DOI: 10.1007/s00428-007-0434-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
15 Gallati S. Disease-modifying genes and monogenic disorders: experience in cystic fibrosis. Appl Clin Genet. 2014;7:133-146. [PMID: 25053892 DOI: 10.2147/tacg.s18675] [Cited by in Crossref: 55] [Cited by in F6Publishing: 28] [Article Influence: 6.9] [Reference Citation Analysis]
16 Wasuwanich P, Karnsakul W. Cystic fibrosis-associated liver disease in children.Minerva Pediatr. 2020;72:440-447. [PMID: 32418413 DOI: 10.23736/S0026-4946.20.05895-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Lamireau T, Monnereau S, Martin S, Marcotte J, Winnock M, Alvarez F. Epidemiology of liver disease in cystic fibrosis: a longitudinal study. Journal of Hepatology 2004;41:920-5. [DOI: 10.1016/j.jhep.2004.08.006] [Cited by in Crossref: 131] [Cited by in F6Publishing: 99] [Article Influence: 7.3] [Reference Citation Analysis]
18 Witt H. Chronic pancreatitis and cystic fibrosis. Gut. 2003;52 Suppl 2:ii31-ii41. [PMID: 12651880 DOI: 10.1136/gut.52.suppl_2.ii31] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 1.0] [Reference Citation Analysis]
19 Slieker MG, Sanders EA, Rijkers GT, Ruven HJ, van der Ent CK. Disease modifying genes in cystic fibrosis. Journal of Cystic Fibrosis 2005;4:7-13. [DOI: 10.1016/j.jcf.2005.05.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
20 Davies JC, Griesenbach U, Alton E. Modifier genes in cystic fibrosis. Pediatr Pulmonol 2005;39:383-91. [PMID: 15765543 DOI: 10.1002/ppul.20198] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
21 Polizzi A, Francavilla R, Castaldo G, Santostasi T, Tomaiuolo R, Manca A, De Robertis F, Mappa L, Oliverio FP, Salvatore F, Rigillo N. Phenotypic expression of genotype-phenotype correlation in cystic fibrosis patients carrying the 852del22 mutation. Am J Med Genet A 2005;132A:434-40. [PMID: 15633186 DOI: 10.1002/ajmg.a.30493] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
22 Petersen KA, Matthiesen F, Agger T, Kongerslev L, Thiel S, Cornelissen K, Axelsen M. Phase I Safety, Tolerability, and Pharmacokinetic Study of Recombinant Human Mannan-Binding Lectin. J Clin Immunol 2006;26:465-75. [DOI: 10.1007/s10875-006-9037-z] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 4.5] [Reference Citation Analysis]
23 Rudnick DA. Cystic fibrosis-associated liver disease: when will the future be now? J Pediatr Gastroenterol Nutr 2012;54:312. [PMID: 21832947 DOI: 10.1097/MPG.0b013e3182309fd0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Nuytinck L, Shapiro F. Mannose-binding lectin: laying the stepping stones from clinical research to personalized medicine. Per Med 2004;1:35-52. [PMID: 29793226 DOI: 10.1517/17410541.1.1.35] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
25 Hansen K, Horslen S. Metabolic liver disease in children. Liver Transpl 2008;14:713-33. [PMID: 18433056 DOI: 10.1002/lt.21520] [Cited by in Crossref: 38] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
26 Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M Jr, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR; Gene Modifier Study Group. Genetic modifiers of liver disease in cystic fibrosis. JAMA 2009;302:1076-83. [PMID: 19738092 DOI: 10.1001/jama.2009.1295] [Cited by in Crossref: 189] [Cited by in F6Publishing: 149] [Article Influence: 14.5] [Reference Citation Analysis]
27 Quaglia A, Roberts EA, Torbenson M. Developmental and Inherited Liver Disease. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 111-274. [DOI: 10.1016/b978-0-7020-6697-9.00003-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Moura TC, Amoras ED, Araújo MS, Freitas Queiroz MA, Conde SR, Demachki S, Martins-Feitosa RN, Machado LF, Cayres-Vallinoto IM, Ishak R, Vallinoto AC. HBV Viral Load and Liver Enzyme Levels May Be Associated with the Wild MBL2 AA Genotype. Mediators Inflamm 2017;2017:3718451. [PMID: 28408790 DOI: 10.1155/2017/3718451] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
29 Finegold MJ. Common diagnostic problems in pediatric liver pathology. Clin Liver Dis. 2002;6:421-454. [PMID: 12122864 DOI: 10.1016/s1089-3261(02)00014-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Corvol H, Flamant C, Vallet C, Clement A, Brouard J. Les gènes modificateurs dans la mucoviscidose. Archives de Pédiatrie 2006;13:57-63. [DOI: 10.1016/j.arcped.2005.09.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
31 Debray D, Corvol H, Housset C. Modifier genes in cystic fibrosis-related liver disease. Curr Opin Gastroenterol 2019;35:88-92. [PMID: 30585791 DOI: 10.1097/MOG.0000000000000508] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 8.5] [Reference Citation Analysis]
32 Hansen K, Horslen S. Metabolic liver disease in children. Liver Transpl 2008;14:391-411. [DOI: 10.1002/lt.21470] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
33 Nash KL, Allison ME, McKeon D, Lomas DJ, Haworth CS, Bilton D, Alexander GJ. A single centre experience of liver disease in adults with cystic fibrosis 1995-2006. J Cyst Fibros. 2008;7:252-257. [PMID: 18042441 DOI: 10.1016/j.jcf.2007.10.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
34 Kilpatrick DC. Mannan-binding lectin and its role in innate immunity. Transfus Med 2002;12:335-52. [PMID: 12473150 DOI: 10.1046/j.1365-3148.2002.00408.x] [Cited by in Crossref: 117] [Cited by in F6Publishing: 102] [Article Influence: 6.2] [Reference Citation Analysis]
35 Mayer-Hamblett N, Kloster M, Ramsey BW, Narkewicz MR, Saiman L, Goss CH. Incidence and clinical significance of elevated liver function tests in cystic fibrosis clinical trials. Contemp Clin Trials 2013;34:232-8. [PMID: 23200843 DOI: 10.1016/j.cct.2012.11.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
36 Davies JC. Modifier genes in cystic fibrosis. Pediatr Pulmonol Suppl 2004;26:86-7. [PMID: 15029608 DOI: 10.1002/ppul.70062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
37 Collaco JM, Cutting GR. Update on gene modifiers in cystic fibrosis. Curr Opin Pulm Med 2008;14:559-66. [PMID: 18812833 DOI: 10.1097/MCP.0b013e3283121cdc] [Cited by in Crossref: 88] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]